This CTD dossier owner and manufacturer is a pharmaceutical manufacturer with a strong commitment to quality and safety. Their products include solid dosage forms like tablets, capsules, sachets, and dry powder suspensions. They focus on research and development, utilizing cutting-edge technologies to meet international standards. The company holds cGMP certifications from the Pharmaceutical Inspection Convention (PIC/s) and has a dedicated team of researchers and regulatory experts. While they operate globally with a presence in diverse regions like the EU and North America, specific therapy areas and product patents are not mentioned.

This CTD dossier owner and manufacturer is a pharmaceutical manufacturer with a strong commitment to quality and safety. Their products include solid dosage forms like tablets, capsules, sachets, and dry powder suspensions. They focus on research and development, utilizing cutting-edge technologies to meet international standards. The company holds cGMP certifications from the Pharmaceutical Inspection Convention (PIC/s) and has a dedicated team of researchers and regulatory experts. While they operate globally with a presence in diverse regions like the EU and North America, specific therapy areas and product patents are not mentioned.

This pharmaceutical company, established in 2009 and acquired by other company. in 2020, boasts state-of-the-art manufacturing facilities adhering to international standards like WHO-GMP, US-FDA, and Australian-TGA guidelines. They operate within the EU, North America, and several countries in Asia and Africa. Their product portfolio includes over 100 registered medications spanning a range of therapy areas including oncology, virology, and hematology. They offer various dosage forms, with a particular focus on generic medications. The company holds multiple product patents and is committed to green initiatives.